Profil
Ashley Ivor Simon Morris served as the Area Director at PT Organon Pharma Indonesia Tbk from 2004 to 2009.
In 2017, he briefly served as the Chief Executive Officer & Executive Director at SciGen Pte Ltd.
Morris obtained his undergraduate degree from The University of Nottingham in 2013.
Anciens postes connus de Ashley Ivor Simon Morris
| Sociétés | Poste | Fin |
|---|---|---|
| SCIGEN LIMITED | Directeur Général | 08/09/2017 |
| MERCK SHARP DOHME PHARMA TBK PT | Corporate Officer/Principal | 01/01/2009 |
Formation de Ashley Ivor Simon Morris
| The University of Nottingham | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MERCK SHARP DOHME PHARMA TBK PT | Health Technology |
| Entreprise privées | 1 |
|---|---|
SciGen Pte Ltd.
 SciGen Pte Ltd. Pharmaceuticals: MajorHealth Technology SciGen Pte Ltd. engages in the development, manufacturing, and marketing of biopharmaceutical products. It operates through following segments: Singapore, Australia, Korea, Thailand, Philippines, China, and Others. The Singapore segment comprises of corporate office functions, sales, and marketing. The Australia, Korea, Thailand, and Philippines segments deal with sales and marketing activities. The China segment is involved in regulatory activities. The Others segment covers operations on in Indonesia, Pakistan, Vietnam, Hong Kong, Myanmar, Malaysia, and profit sharing income on sale of insulin. The firm's products include SciLin, SciTropin A, SciLocyte, SciTrace 5 Injection, and Heri Injection. The company was founded by Saul Akerib Mashaal in 1988 and is headquartered in Singapore. | Health Technology |